Sabar Karimah Es

SEC source: 0001873796-26-000006 · form4-04032026_050401.xml · derivative · entry 3

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 161

Underlying: Common Stock · 7,529 shares

Expires 2032-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Shares vested 1/48th on the first day of each month commencing February 1, 2022.

SEC source: 0001873796-26-000006 · form4-04032026_050401.xml · nonDerivative · entry 2

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001873796-26-000006 · form4-04032026_050401.xml · nonDerivative · entry 1

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,529

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001873796-26-000004 · form4-04012026_080408.xml · derivative · entry 6

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 53,735 shares

Expires 2031-07-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Shares vested 25% on August 1, 2022 with the remainder vesting 1/36 per month commencing September 1, 2022.

SEC source: 0001873796-26-000004 · form4-04012026_080408.xml · nonDerivative · entry 4

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.28 to $31.39, inclusive.

SEC source: 0001873796-26-000004 · form4-04012026_080408.xml · nonDerivative · entry 3

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,735

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001873796-26-000004 · form4-04012026_080408.xml · derivative · entry 5

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,735

Underlying: Common Stock · 61,265 shares

Expires 2031-07-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Shares vested 25% on August 1, 2022 with the remainder vesting 1/36 per month commencing September 1, 2022.

SEC source: 0001873796-26-000004 · form4-04012026_080408.xml · nonDerivative · entry 2

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.46, inclusive.

SEC source: 0001873796-26-000004 · form4-04012026_080408.xml · nonDerivative · entry 1

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,265

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001873796-26-000002 · form4-01072026_040113.xml · derivative · entry 1

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,500

Underlying: Common Stock · 15,500 shares

Expires 2036-01-05

F1 · derivative.exercise_date: The shares vest 1/12th of the first day of each month, commencing February 1, 2026, with the last month vesting on December 31, 2026, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.

SEC source: 0001415889-25-000871 · form4-01062025_070111.xml · derivative · entry 3

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,750

Underlying: Common Stock · 5,750 shares

Expires 2035-01-02

F3 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board service.

SEC source: 0001415889-25-000871 · form4-01062025_070111.xml · derivative · entry 2

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,520

Underlying: Common Stock · 2,520 shares

Expires 2035-01-02

F2 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board committee service.

SEC source: 0001415889-25-000871 · form4-01062025_070111.xml · derivative · entry 1

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,940

Underlying: Common Stock · 11,940 shares

Expires 2035-01-02

F1 · derivative.exercise_date: The shares vest 1/12th of the first day of each month, commencing February 1, 2025, with the last month vesting on December 31, 2025, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.

SEC source: 0001415889-24-000655 · form4-01042024_050116.xml · derivative · entry 3

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,280

Underlying: Common Stock · 14,280 shares

Expires 2034-01-02

F3 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board service.

SEC source: 0001415889-24-000655 · form4-01042024_050116.xml · derivative · entry 2

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,460

Underlying: Common Stock · 4,460 shares

Expires 2034-01-02

F2 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board committee service.

SEC source: 0001415889-24-000655 · form4-01042024_050116.xml · derivative · entry 1

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,250

Underlying: Common Stock · 29,250 shares

Expires 2034-01-02

F1 · derivative.exercise_date: The shares vest 1/12th of the first day of each month, commencing February 1, 2024, with the last month vesting on December 31, 2024, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.

SEC source: 0001415889-23-000597 · form4-01052023_080158.xml · derivative · entry 2

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2033-01-03

F2 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 3, 2023, the date of the grant. The award pertains to annual board service.

SEC source: 0001415889-23-000597 · form4-01052023_080158.xml · derivative · entry 1

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,770

Underlying: Common Stock · 37,770 shares

Expires 2033-01-03

F1 · derivative.exercise_date: The shares vest 1/12th of the first day of each month, commencing February 1, 2023, with the last month vesting on December 31, 2023, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.

SEC source: 0001415889-23-000634 · form4a-01062023_050101.xml · derivative · entry 1

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,560

Underlying: Common Stock · 3,560 shares

Expires 2033-01-03

F1 · derivative.exercise_date: The shares of the award are fully vested and exercisable as of January 3, 2023, the date of the grant.

SEC source: 0001415889-22-000283 · form4-01042022_090148.xml · derivative · entry 1

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,690

Underlying: Common Stock · 7,690 shares

Expires 2032-01-03

F1 · derivative.exercise_date: The shares vest 1/48th of the first day of each month, commencing February 1, 2022, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.

SEC source: 0001104659-21-096408 · tm2123420-1_4seq1.xml · derivative · entry 1

Sabar Karimah Es · CIK 0001873796 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2031-07-23

F1 · derivative.exercise_date: The shares vest 25% on the first anniversary of the first day of the month following the Grant Date, with the remainder to vest at the rate of 1/36 per month thereafter. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.